HWAM
Hennion & Walsh Asset Management’s Aldeyra Therapeutics ALDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-69,442
| Closed | -$399K | – | 919 |
|
|
2025
Q1 | $399K | Sell |
69,442
-16,006
| -19% | -$92K | 0.02% | 697 |
|
|
2024
Q4 | $426K | Sell |
85,448
-1,588
| -2% | -$7.92K | 0.02% | 663 |
|
|
2024
Q3 | $469K | Sell |
87,036
-1,086
| -1% | -$5.85K | 0.02% | 635 |
|
|
2024
Q2 | $292K | Buy |
88,122
+6,944
| +9% | +$23K | 0.02% | 735 |
|
|
2024
Q1 | $265K | Buy |
81,178
+1,977
| +2% | +$6.47K | 0.01% | 732 |
|
|
2023
Q4 | $278K | Buy |
79,201
+5,532
| +8% | +$19.4K | 0.02% | 700 |
|
|
2023
Q3 | $492K | Buy |
73,669
+34,796
| +90% | +$232K | 0.03% | 524 |
|
|
2023
Q2 | $326K | Buy |
+38,873
| New | +$326K | 0.02% | 631 |
|